Mitoxantrone trial in multiple sclerosis [8] (multiple letters)

Lancet

Volumn 361, Issue 9363, 2003, Pages 1133-1134

  Chaudhuri, Abhijit ^a   Behan, Peter O ^a   Hartung, Hans Peter ^b  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; MITOXANTRONE; PLACEBO;

ACUTE LEUKEMIA; ALOPECIA; AMENORRHEA; AUTOIMMUNE DISEASE; AXONAL INJURY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN INJURY; CARDIOTOXICITY; CLINICAL TRIAL; CORRELATION ANALYSIS; DATA ANALYSIS; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; ENCEPHALOMYELITIS; GONADAL DISEASE; HEALTH CARE FACILITY; HUMAN; IMMUNOTHERAPY; INFECTION; INFLAMMATION; LETTER; MORBIDITY; MORTALITY; MULTIPLE SCLEROSIS; NAUSEA; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

EID: 0037471788     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12875-9     Document Type: Letter

References (5)

1. H-P Hartung R Gonsette N Konig Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial Lancet 360 2002 2018 2025
2. M Fillipi M Bozzali M Rovaris Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis Brain 126 2003 433 437
3. C Confraveux S Vukusic T Moreau P Adeleine Relapses and progression of disability in multiple sclerosis N Engl J Med 343 2000 1430 1438
4. PA Narayana TJ Doyle D Lai JS Wolinsky Serial proton magnetic resonance spectroscopy imaging, contrast enhanced magnetic resonance imaging and quantitative lesion volumetry in multiple sclerosis Ann Neurol 43 1998 56 71
5. PO Behan A Chaudhuri BO Roep The pathogenesis of multiple sclerosis revisited J R Coll Physicians Edinb 32 2002 244 265